Wednesday, June 22, 2022

DEXLEVO completes 26 billion won pre-IPO funding, prompting GOURI international marketing

 

GOURI, a liquid PCL injection developed by DEXLEVO (Photo: Business Wire) 

KUALA LUMPUR, June 21 (Bernama) -- As the spread of COVID-19 has slowed down worldwide, the demand for skincare is expected to increase, and expectations for the rapid growth of the skincare market are also growing, with countries such as the United States, United Kingdom, and Germany having lifted measures to wear masks outdoors, and there is a trend to abolish the measures to wear masks in public transportation.

This can be recognised as good news for companies in the beauty industry with a high proportion of overseas exports.

DEXLEVO, a company specialising in cosmetic medical devices, has completed pre-IPO funding of 26 billion won for existing investors, Magna Investment, Smilegate Investment, Hyundai Technology Investment, and Shinhan Capital. It is preparing for listing in 2023, and DEXLEVO has set a post value of 276 billion won after investment. 

DEXLEVO was established in 2013 by Jaewon Yoo, a former researcher at Samyang Corporation, and succeeded in liquefying Polycaprolactone (PCL), a biodegradable polymer, for the first time in the world.

According to a statement, based on this technology, DEXLEVO developed a liquid PCL injection 'GOURI' and participated in the world's largest beauty fair AMWC (Aesthetic and Anti-aging Medicine world Congress) in September of last year and March of this year as a main sponsor to announce GOURI’s technological prowess and excellence.

It will also participate in the International Master Course on Aging Science (IMCAS) held in Paris this June to spur marketing activities to increase its global market share.

Unlike existing fillers, as GOURI is in a liquid form without particulates, it spreads throughout the face when injected and induces collagen formation.

DEXLEVO is expanding its beauty market share with not only GOURI, a cosmetic medical device, but also KABELLINE, a contour product, and Touch BR, a whitening product.

Currently, DEXLEVO is focusing on distribution in Southeast Asian regions such as Indonesia, Vietnam, and Thailand. KABELLINE is reaching the Americas.

For more information, visit www.dexlevoaesthetic.com.

-- BERNAMA

No comments:

Post a Comment